STOCK TITAN

Thermon (THR) Form 4: Director Receives 1,008 Shares; Ownership 40,299

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4

Rhea-AI Filing Summary

John U. Clarke, a director of Thermon Group Holdings, Inc. (THR), received 1,008 shares of Common Stock as an award under the company's Non-Employee Director Compensation Program on 10/01/2025 at a reported price of $27.28 per share. After the transaction, Mr. Clarke is reported to beneficially own 40,299 shares in a direct ownership form. The Form 4 was signed by an attorney-in-fact, Ryan Tarkington, on 10/02/2025. The filing documents the routine grant to a director and lists no derivative transactions or additional conditions in the reported sections.

Positive

  • Director award granted: 1,008 shares awarded under the Non-Employee Director Compensation Program, aligning director interests with shareholders
  • Increased insider ownership: Reported direct beneficial ownership rose to 40,299 shares

Negative

  • None.

Insights

TL;DR: Routine director equity award increases insider ownership modestly; no derivatives or dispositions reported.

The transaction is a standard equity grant under the Non-Employee Director Compensation Program, adding 1,008 shares at $27.28 and raising direct beneficial ownership to 40,299 shares. This is a non-cash compensation event that slightly increases insider alignment with shareholders but appears non-material to company capitalization given the absolute share count disclosed. No sales, option exercises, or debt-related changes are reported.

TL;DR: Governance-normal grant to a director; disclosure meets Section 16 reporting standards.

The Form 4 discloses a director award and proper reporting by an authorized representative. The filing specifies the award source and ownership form as direct. There are no indications of exceptional governance issues, departures, or related-party transfers in the disclosed content. Documentation appears routine and compliant with required insider-reporting obligations.

Insider CLARKE JOHN U
Role Director
Type Security Shares Price Value
Grant/Award Common Stock 1,008 $27.28 $27K
Holdings After Transaction: Common Stock — 40,299 shares (Direct)
Footnotes (1)
  1. [object Object]
SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
CLARKE JOHN U

(Last) (First) (Middle)
7171 SOUTHWEST PARKWAY
BUILDING 300, SUITE 200

(Street)
AUSTIN TX 78735

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Thermon Group Holdings, Inc. [ THR ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
10/01/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock 10/01/2025 A 1,008(1) A $27.28 40,299 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. Award pursuant to Issuer's Non-Employee Director Compensation Program.
Remarks:
/s/ Ryan Tarkington, Attorney-in-Fact 10/02/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did THR director John U. Clarke report on Form 4?

The Form 4 reports an award of 1,008 shares of Common Stock on 10/01/2025 priced at $27.28, increasing direct beneficial ownership to 40,299 shares.

Was the Form 4 filing for THR a sale or purchase transaction?

The filing documents an award (A), not a purchase or sale; no dispositions or derivative transactions are reported.

Under what program were the 1,008 shares awarded?

The shares were awarded pursuant to the issuer's Non-Employee Director Compensation Program as stated in the filing.

Who signed the Form 4 for John U. Clarke?

The Form 4 was signed by Ryan Tarkington, Attorney-in-Fact on 10/02/2025.

Does the filing show any derivative securities or option exercises for THR?

No. Table II for derivative securities shows no entries; the filing discloses only the non-derivative stock award.